- Home
- STRS vs ZURA Comparison
STRS vs ZURA Comparison
Compare STRS & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- ZURA
- Stock Information
- Founded
- STRS 1992
- ZURA 2022
- Country
- STRS United States
- ZURA United States
- Employees
- STRS N/A
- ZURA N/A
- Industry
- STRS Homebuilding
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRS Real Estate
- ZURA Health Care
- Exchange
- STRS Nasdaq
- ZURA Nasdaq
- Market Cap
- STRS 150.3M
- ZURA 137.2M
- IPO Year
- STRS N/A
- ZURA N/A
- Fundamental
- Price
- STRS $18.90
- ZURA $3.68
- Analyst Decision
- STRS
- ZURA Strong Buy
- Analyst Count
- STRS 0
- ZURA 9
- Target Price
- STRS N/A
- ZURA $11.38
- AVG Volume (30 Days)
- STRS 6.1K
- ZURA 497.8K
- Earning Date
- STRS 11-12-2025
- ZURA 11-13-2025
- Dividend Yield
- STRS N/A
- ZURA N/A
- EPS Growth
- STRS N/A
- ZURA N/A
- EPS
- STRS N/A
- ZURA N/A
- Revenue
- STRS $31,912,000.00
- ZURA N/A
- Revenue This Year
- STRS N/A
- ZURA N/A
- Revenue Next Year
- STRS N/A
- ZURA N/A
- P/E Ratio
- STRS N/A
- ZURA N/A
- Revenue Growth
- STRS N/A
- ZURA N/A
- 52 Week Low
- STRS $15.10
- ZURA $0.97
- 52 Week High
- STRS $27.00
- ZURA $4.68
- Technical
- Relative Strength Index (RSI)
- STRS 61.26
- ZURA 48.77
- Support Level
- STRS $18.60
- ZURA $3.78
- Resistance Level
- STRS $19.19
- ZURA $4.10
- Average True Range (ATR)
- STRS 0.42
- ZURA 0.32
- MACD
- STRS 0.13
- ZURA -0.08
- Stochastic Oscillator
- STRS 100.00
- ZURA 23.05
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.